Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HerpV + QS-21 in recurrent genital herpes
NCT01687595Phase 2Completed
- Sponsor
- Agenus Inc.
- Start
- Oct 2012
- Primary completion
- Sep 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of HerpV in genital herpes, sponsored by Agenus Inc.. Started Oct 2012; status: completed.
02
Drugs
HerpV
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT01687595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687595.